(Q34172130)

31 July 2017

1 reference

title

Cellular HIV-1 immune responses in natural infection and after genetic immunization. (English)

1 reference

31 July 2017

Calarota SA

1

1 reference

31 July 2017

Wahren B

series ordinal

2

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

33

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

83-96

1 reference

Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

DNA increases the potency of vaccination against infectious diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Gene inoculation generates immune responses against human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Rapid effector function in CD8+ memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Protective immunity against HIV infection: has nature done the experiment for us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Viral mutations, TCR antagonism and escape from the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Effects of HIV-1 Tat on expression of HLA class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Virus escape from CTL recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

T cell responses and viral escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Effect of therapeutic immunization with recombinant gp160 HIV-1 vaccine on HIV-1 proviral DNA and plasma RNA: relationship to cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Gene vaccination: plasmid DNA is more than just a blueprint

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Plasmid DNA vaccination: mechanism of antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Nucleic acid vaccines: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

HIV accessory proteins as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Potential DNA vaccine integration into host cell genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

A lectin-binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Cross-clade T cell recognition of HIV.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Persisting human immunodeficiency virus type 1 gp160-specific human T lymphocyte responses including CD8+ cytotoxic activity after receipt of envelope vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Role of Cellular Immunity in Protection against HIV Infection**This article was accepted for publication on 31 October 1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

HIV-specific cytotoxic T lymphocytes in seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Cytotoxic T lymphocytes in human immunodeficiency virus infection: regulator genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Immune correlates of protection from HIV and AIDS – more answers but yet more questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Cytotoxic T lymphocytes in HIV-1 infection: a killing paradox?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Early T-helper cell defects in HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Induction of specific T-cell responses in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Therapeutic immunisation with recombinant gp160 in HIV-1 infection: a randomised double-blind placebo-controlled trial. Nordic VAC-04 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401750065445

10.1080/003655401750065445

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference